Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders

 
 

PENWEST PHARMACEUTICALS CO (PPCO) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.21 Metrics
OS: 31.8 M 49 % ROE
Market cap: $134 M 79 % ROIC
Net cash: $14.4 M $0.45 per share
EV: $120 M

 
TTM Valuation
EBITDA $15.3 M 7.8 x EV/EBITDA
EBIT $14.4 M 8.3 x EV/EBIT
EPS $0.43 9.7 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues23.88.53.33.56.25.14.75.5
            Revenue growth179.0%158.0%-5.5%-43.7%21.6%9.2%-15.5%-4.5%
Cost of goods sold2.71.40.60.20.00.10.20.2
Gross profit21.27.12.73.36.25.04.55.4
            Gross margin88.9%83.1%81.7%93.4%99.4%98.0%96.4%96.9%
Selling, general and administrative9.412.114.314.113.29.510.47.6
Research and development12.421.023.622.917.820.220.617.0
EBITA-0.4-25.6-34.7-33.1-24.4-24.3-26.2-19.0
            EBITA margin-1.7%-300.3%-1050.2%-946.0%-392.8%-475.3%-560.6%-343.0%
Amortization of intangibles0.30.40.40.60.50.40.20.2
EBIT-0.7-26.0-35.1-33.7-24.9-24.7-26.4-19.2
            EBIT margin-2.9%-304.6%-1061.6%-962.1%-400.3%-483.3%-565.2%-346.0%
Pre-tax income-1.5-26.7-34.5-31.3-22.9-23.8-26.0-19.0
Income taxes0.00.00.00.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%    
Earnings from continuing ops-1.5-26.7-34.5-31.3-22.9-23.8-26.0-19.0
Earnings from discontinued ops      10.11.9
Net income-1.5-26.7-34.5-31.3-22.9-23.8-15.9-17.1
            Net margin-6.3%-313.3%-1041.9%-894.9%-368.5%-465.6%-340.6%-308.8%
 
Diluted EPS($0.05)($0.89)($1.48)($1.38)($1.05)($1.28)($1.56)($1.23)
Shares outstanding (diluted)31.729.923.222.821.718.616.715.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy